MedTech startup ecosystem
We track 63 organisations in this sector across 6+ countries.
Showing 41–60 of 63MedTech
Countries in this sector
Sectors alongside this one
MedTech results
MSInsight
Develops MSIcare, bioinformatics software that analyses microsatellite instability biomarkers from next-generation sequencing data to guide oncologists in selecting targeted immunotherapy across cancer types. Winner of France's i-Lab 2023.
Neulogy Ventures
Neulogy Ventures is one of the leading deeptech venture capital funds in Central and Eastern Europe, established in 2014 and operating from Bratislava with a Luxembourg fund structure. It manages €65 million in assets under management across approximately 30 portfolio companies in 10 countries, writing cheques of €200,000–€3 million primarily at Seed and Series A stages. The fund targets mission-driven Slovak and CEE technology companies addressing climate change, healthcare, and industrial automation. Institutional co-investors include the European Investment Fund, Slovak Investment Holding, and Tatra banka.
Neuraccure
Monaco digital health company in the MonacoTech portfolio, building iPad applications for advanced neurological examination. Its Vision tool handles video oculography and Synapse runs multidimensional neurological testing, together aimed at detecting subtle abnormalities at preclinical stages that a conventional bedside examination would miss.
Neurobalance
Andorra la Vella clinic on the national innovative-companies map under health and biotech, working in non-invasive neuromodulation. It applies low-frequency microcurrents to stimulate the autonomic nervous system for sleep disorders, stress and emotional regulation, combining neuromodulation with biofeedback, physiotherapy, nutrition and coaching in personalised plans.
Neuromedical
Polish-Israeli medtech startup developing VGuard, a non-invasive vagus nerve stimulation system aimed at improving cognitive outcomes in patients with Alzheimer’s disease and dementia. The company is advancing clinical validation and regulatory pathways across Europe and the US.
Neuromod Devices
Medical-device company developing bimodal neuromodulation technology. Its flagship product Lenire is the first FDA-approved bimodal neuromodulation tinnitus treatment, available in 130+ clinics across the US and Europe. Founded 2010.
Nordic Innovation Fair 2026 (September 2026)
A two-day Nordic deep-tech and research-commercialisation matchmaking fair at Industriens Hus in Copenhagen under the 2026 theme of defence, resilience and safety. Tracks cover quantum, AI and digital, greentech and food, biotech and pharma, and medtech and diagnostics, connecting startups, researchers and industry across the Nordics.
Novetech Surgery
Nice-based medical device company on Boulevard du Tzarewitch that designs, manufactures and distributes minimally invasive orthopaedic implants for veterinary surgery. Its range covers synthetic ligament and tendon reconstruction, bone surgery and visceral implants, alongside professional training for veterinary surgeons. The company is an alumnus of the MonacoTech incubator across the nearby border.
Nursinnov
Monaco medical device company in the MonacoTech portfolio, founded by a specialised nurse with twenty-five years in the field. It develops patented ergonomic devices aimed at reducing blood exposure accidents during dialysis, and pairs them with simulation-based training and consulting for healthcare teams.
Panakès Partners
Founded in 2015, Panakes Partners is a Milan-based healthcare VC investing EUR 1-8M at Series A and B in medical devices, diagnostics, digital health, and biotech across Europe. The firm manages over EUR 100M and focuses on companies with clear clinical evidence and regulatory pathways. Portfolio includes MMI (surgical robotics, IPO on Euronext), Novavido, and Kither Biotech. The team of medtech executives and clinicians provides hands-on support in clinical trials, CE marking, and commercialization.
Pixacare
Pixacare is a Strasbourg-based medtech company providing a medical photography and wound-care platform used by hospitals to document, measure, and remotely monitor chronic, post-surgical, and dermatological wounds. Its WoundTrack-II module is a CE-marked Class IIa AI medical device that automatically measures wound surface area and tissue composition from photographs, while the core app carries a CE Class I marking. The platform is used by more than 50 hospitals and clinics, has documented over 1 million lesions for more than 200,000 patients, and reports clinical studies showing reduced healing time and fewer in-person consultations with remote wound monitoring.
Revolab
HealthTech company offering a CE-certified at-home finger-prick blood collection kit and digital platform; samples ship to partner labs and users get lab-grade results for 30+ tests within 24 hours.
Robeauté
Develops grain-of-rice-sized microrobots designed to navigate inside the human brain to deliver therapeutic molecules, implant electrodes or collect cellular data, aiming to make neurosurgery safer and more precise for conditions including glioblastoma.
SANTEXPO 2026
Major French healthcare and hospital innovation expo with a large innovation village for digital health ventures. High-value event for founders targeting public-hospital procurement and clinical pilot partnerships.
Semirobotics
Semirobotics is a Warsaw-based medtech robotics startup that developed FIDI, an assistive feeding robot designed for people with upper-limb disabilities who cannot eat independently. The system combines 3D vision, AI-based motion planning, and adaptive utensils to align with the user's posture, pace, and food preferences, restoring dignity and autonomy during meals. Semirobotics targets hospitals, care homes, and individual users, addressing a significant unmet need in assistive technology. The company is part of Poland's emerging robotics and medtech scene and has received EU innovation funding.
Swiss Medtech Expo 2026 (September 2026)
Switzerland's leading biennial medtech trade fair for development, manufacturing and supply, organized by Messe Luzern. Around two hundred exhibitors plus a conference and innovation program draw engineers, manufacturers, suppliers and medtech startups. It is relevant to medtech founders for sourcing, partnerships and showcasing solutions in one of Switzerland's strongest industrial clusters.
Sword Health
Sword Health is a Portuguese digital health company focused on musculoskeletal care delivered through a mix of sensors, software, and remote clinical support. The company became prominent by showing that physical therapy does not need to depend entirely on repeated in-person visits when patient motion can be measured remotely and paired with continuous guidance from licensed professionals. Its model combines wearable motion tracking, AI-assisted feedback, and human clinicians into a structured care program that large employers and health plans can offer at scale. That makes Sword Health more than a telehealth app; it is a vertically integrated care-delivery product with hardware, data, and clinical workflow built together. In the European startup ecosystem, Sword Health is a strong example of how deep health-tech products can emerge from the region and sell into highly demanding enterprise buyers in healthcare and HR. It also broadens the directory's coverage of sensor-driven health platforms by linking medical use cases with the kinds of product, data, and device capabilities that have made other European health companies successful.
Tech2b
tech2b is a startup incubator in Upper Austria, based in Linz, that supports innovative, future-oriented founders in building and scaling their businesses. It runs a structured pipeline of programmes — IDEATE, ACTIVATE and INCUBATE — plus sector-specific tracks including a tourism incubator (#tourismusinkubator), Business2Excellence, and PIER4, with focus areas spanning diversity-led founding teams, hardware, greentech and medtech. It offers coaching, funding access and connections across the regional Upper Austrian innovation ecosystem, and runs the annual EDISON startup awards.
Velocity.Partners
Velocity.Partners was founded in 2017 in Athens, growing out of the Found.ation startup ecosystem, and is supported by the EquiFund programme and the EU Operational Programme "Competitiveness, Entrepreneurship & Innovation". The fund is sector-agnostic but has particular depth in Maritime-tech, MedTech, FinTech, and Travel-tech — verticals where Greek founders hold a structural edge. It invests at pre-seed and seed stage with initial tickets typically up to €500K, then follows on into later rounds. The team combines operators, founders, and investors with hands-on industry experience.
Venture Catalysts
Venture Catalysts is an innovative venture studio and venture builder program based in Porto, Portugal, specializing in spinning up companies from scientific research and technical projects. Founded around 2015 (with roots as a university initiative), Venture Catalysts takes a hands-on approach to pair scientists and engineers with business co-founders to create startups in fields like medtech, cleantech, and AI. The program identifies promising technologies (often from local universities like University of Porto or from labs across Portugal) and provides a structured process to form a company, develop an MVP, and obtain early funding. Each year, it selects a batch of projects and offers resources such as lab access, initial capital (seed grants or investment from partnered funds), and a network of corporate partners for pilots. A distinctive feature is how it integrates venture building with funding: Venture Catalysts can provide seed capital through grants or its partnered VC funds (often up to €200k), and also connects teams with larger investors for follow-ons. The studio’s track record includes helping create SWORD Health (digital physiotherapy startup that became a unicorn) and AddVolt (electric truck battery solution acquired by Daimler). These successes highlight the model’s efficacy – both companies started as technical projects in Portugal and through Venture Catalysts’ support, gained product-market fit and international traction. The venture studio is backed by both private and public stakeholders (it has worked with Portugal’s innovation agency and corporates like EDP in energy tech). Located in Porto’s up-and-coming innovation district, Venture Catalysts has contributed to making Porto a deep-tech startup hub beyond the usual Lisbon scene. The program puts heavy emphasis on team formation – often recruiting experienced entrepreneurs or MBAs to join scientific founders as CEOs or business leads, ensuring startups have both technical depth and commercial acumen. With a regional focus, it has kept many high-tech startups in Northern Portugal, strengthening the local ecosystem. In summary, Venture Catalysts serves as a venture co-founder for scientists – turning lab breakthroughs into viable companies by providing the missing pieces (business talent, early capital, industry links). Its portfolio’s achievements, like SWORD Health’s growth, demonstrate the powerful potential of the venture studio model in catalyzing innovation.
